Výsledky vyhledávání

Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts

Autor: Massimo Cigolini, G Mezzena, Elena Barzon, Giuliano Soffiati, Davide Giavarina

Publikováno v: Nutrition, Metabolism and Cardiovascular Diseases. 17:311-318

Background and aims Guidelines for the primary prevention of cardiovascular disease recommend the use of risk-assessment methods to identify high risk patients who can benefit from lifestyle changes and/or drug treatment. Although all these risk-pred

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8359204375d287620bbdd26744060925
https://doi.org/10.1016/j.numecd.2005.12.008

Zobrazit plný text záznamu

Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism

Autor: Andrea Rubboli, Gian Luca Spadaro, G Mezzena, Filippo Ottani, C Boanno, A. Fontanelli, Luca Favero, A S Jaffe, L La Vecchia

To investigate the frequency of cardiac troponin I (cTnI) increases in patients with pulmonary embolism (PE) and to assess the correlation between this finding, the clinical presentation, and outcomes.Consecutive patients admitted to the coronary car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6a4d00413bab8620a927f74cffcc378
https://europepmc.org/articles/PMC1768297/

Zobrazit plný text záznamu

[Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors]

Autor: G M, Benvenuto, L, La Vecchia, P, Morandi, P, Ruffini, G, Mezzena

Publikováno v: Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology. 1(11)

High-dose cyclophosphamide is the nucleus for virtually all high-dose chemotherapy protocols. Non-hematologic dose-limiting toxicity is represented by acute cardiomyopathy, even fatal in a minority of patients. The pathophysiology of such a cardiotox

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0b9b305a0a25e2d145f0e6b3b049da16
https://pubmed.ncbi.nlm.nih.gov/11109196

Zobrazit plný text záznamu

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

Autor: Luigi La Vecchia, Mariemma Paccanaro, R. Ometto, Luisa Zanolla, Carlo Bonanno, Leonardo Varotto, G Mezzena

Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 19(7)

Background Cardiac cell death has been shown to occur in heart failure and has been implicated as one of the mechanisms responsible for progression of the disease. Cardiac Troponin I (cTnI) represents a highly sensitive marker for myocardial cell dea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22644eb62c6d4a38ed95282bab6be911
https://pubmed.ncbi.nlm.nih.gov/10930813

Zobrazit plný text záznamu

Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide

Autor: G Mezzena, R Raimondi, L La Vecchia, Paolo Morandi, G M Benvenuto, Pier Adelchi Ruffini

Publikováno v: Bone marrow transplantation. 28(3)

High-dose cyclophosphamide (HD-CTX) is largely employed in high-dose chemotherapy (HD-CHT) protocols. HD-CTX dose-limiting toxicity expresses itself as cardiac toxicity which is fatal in a minority of patients. The pathophysiology of HD-CTX-associate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c859faa7c36a9fd72fb1825cdee7521
https://pubmed.ncbi.nlm.nih.gov/11535996

Zobrazit plný text záznamu

Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin

Autor: L, La Vecchia, G, Mezzena, R, Ometto, G, Finocchi, F, Bedogni, G, Soffiati, M, Vincenzi

Publikováno v: The American journal of cardiology. 80(1)

Cardiac troponin I, a specific and sensitive marker of myocardial damage, was detected in the blood of 6 of 26 patients studied in our Heart Failure Clinic. In these patients functional class, ventricular function, and prognosis were significantly wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fb15821875b7c2cd954c733c145e0309
https://pubmed.ncbi.nlm.nih.gov/9205029

Zobrazit plný text záznamu

[Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty]

Autor: L, La Vecchia, F, Bedogni, G, Finocchi, G, Mezzena, M, Martini, M, Sartori, A, Castellani, G, Soffiati, M, Vincenzi

Publikováno v: Cardiologia (Rome, Italy). 42(4)

The development of methods for the detection of circulating CK-MB mass, cardiac troponin T (cTn-T) and troponin I (cTn-I) has increased the diagnostic potential in the identification of myocardial damage. Coronary angioplasty (PTCA) represents a wide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::edd035de4410981975c762d5a7ce9ea0
https://pubmed.ncbi.nlm.nih.gov/9244645

Zobrazit plný text záznamu

Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting

Autor: Sartori M, A. Castellani, Vincenzi M, Finocchi G, M. Martini, Guiliano Soffiati, Luigi La Vecchia, Francesco Bedogni, G Mezzena

Publikováno v: ResearcherID

OBJECTIVE To assess whether and to what extent elective coronary stenting is associated with biochemical evidence of minor myocardial damage (MMD), as defined by the detection of abnormal post-procedural serum levels of one more among the following m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2014a285d622342de05c3b546953630c
https://pubmed.ncbi.nlm.nih.gov/8913672

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání